Mingwei Ma, MD

Peking University First Hospital

Beijing, Beijing

Mingwei Ma, MD, PhD
Peking University First Hospital
Beijing, China

Dr. Ma is an attending physician, Assistant Professor, and Associate Researcher in the Department of Radiation Oncology at Peking University First Hospital, and serves as Secretary of the PUMC–NCC East Hospital Joint Research Center. Her clinical practice and research focus on stereotactic ablative radiotherapy for metastatic renal cell carcinoma and intensified multimodal therapy for high-grade prostate cancer. Dr. Ma earned her Master of Science in Oncology and her Professional PhD in Oncology from Peking University Health Science Center. She completed standardized residency training in Radiation Oncology at the Cancer Hospital of CAMS & PUMC, followed by residency and attending physician roles at Peking University First Hospital. Recognized as an Outstanding Young Physician in 2024 and named a Peking University Clinical Scientist in 2025, she has authored 11 papers in SCI-indexed journals. Dr. Ma is leads multiple projects funded at the provincial, university, and hospital levels.

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 28

120 - 5-Year Results of a Prospective, Non-Randomized Controlled Study: Comparison of the Efficacy and Safety of ADT + Docetaxel vs. ADT + Novel Hormone Therapy in High Gleason Score Non-Metastatic Prostate Cancer Patients Receiving Radiotherapy

Room 24

03:30pm - 03:35pm PT

Sep 29

3100 - Preclinical Evaluation of a Novel In Situ Biomimetic Mineralization Radioprotective Absorbable Gel for Prostate Cancer Radiotherapy

Hall F

05:00pm - 06:00pm PT

Sep 30

3281 - Combination of Axitinib, Toripalimab, and Radical-Dose Radiotherapy for Recurrent or Metastatic Renal Cell Carcinoma: A Single-Center Prospective Study

Hall F

12:45pm - 02:00pm PT